Global Addictions Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024
SKU ID :GIR-14748898 | Published Date: 06-Dec-2019 | No. of pages: 102Description
Description
The global Addictions Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Addictions Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Addictions Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Addictions Therapeutics market by product type and applications/end industries.
Alkermes Plc
Opiant Pharmaceuticals Inc.
Johnson & Johnson Services Inc.
Amneal Pharmaceuticals Inc.
Novo Nordisk AS
Indivior Plc
Teva Pharmaceutical Industries Ltd.
Novartis AG
Mylan NV
Pfizer Inc.
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Public
Private
Government
Scope of the Report:
The global Addictions Therapeutics market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Addictions Therapeutics.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Addictions Therapeutics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Addictions Therapeutics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Alkermes Plc
Opiant Pharmaceuticals Inc.
Johnson & Johnson Services Inc.
Amneal Pharmaceuticals Inc.
Novo Nordisk AS
Indivior Plc
Teva Pharmaceutical Industries Ltd.
Novartis AG
Mylan NV
Pfizer Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Alcohol Addiction Therapeutics
Tobacco Addiction Therapeutics
Drug Addiction Therapeutics
Market Segment by Application
s, can be divided into
Public
Private
Government
TOC
Tables & Figures
Companies
- PRICE
-
$3480$6960Buy Now